Philip Morris International Inc. Stock Rises Tuesday, Still Underperforms Market

Spectrum Pharmaceuticals Inc

Change company Symbol lookup

Select an option...

SPPI Spectrum Pharmaceuticals Inc

FDBC Fidelity D&D Bancorp Inc

$BUKCHET Bloomberg Coffee Subindex Euro

BMY Bristol-Myers Squibb Co

MLGO MicroAlgo Inc

FRST Primis Financial Corp

VII 7GC & Holdings Co Inc

PEBO Peoples Bancorp Inc

BIOAF Bioasis Technologies Inc

NRGOF Newrange Gold Corp

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value

Company profile

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing targeted oncology therapies. The Company's product portfolio consists of in-development drug products for the treatment of cancer patients. The Company's pipeline products include Eflapegrastim and Poziotinib. The Eflapegrastim is a long-acting granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced neutropenia. Poziotinib is a, pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR) family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations. The Eflapegrastim employs a LAPSCOVERY technology to enhance the duration of therapeutic effects and reduce the frequency of administration.

Philip Morris International Inc. Stock Rises Tuesday, Still Underperforms Market

5:17 pm ET November 22, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Philip Morris International Inc. (PM) inched 0.27% higher to $97.16 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.36% to 4,003.58 and the Dow Jones Industrial Average rising 1.18% to 34,098.10. This was the stock's sixth consecutive day of gains. Philip Morris International Inc. closed $15.32 below its 52-week high ($112.48), which the company achieved on February 18th.

The stock underperformed when compared to some of its competitors Tuesday, as Altria Group Inc. (MO) rose 0.80% to $45.16, British American Tobacco PLC ADR (BATS.LN) rose 0.76% to $39.98, and Imperial Brands PLC ADR (IMB.LN) rose 0.83% to $25.63. Trading volume (2.9 M) remained 1.8 million below its 50-day average volume of 4.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 22, 2022.

(END) Dow Jones Newswires

November 22, 2022 17:17 ET (22:17 GMT)